TCL Archive ODAC To Advise FDA on First Biosimilars Application Jan. 7 By Cancer History Project December 19, 2014
TCL Archive ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote By Cancer History Project June 27, 2014
TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals By Cancer History Project September 20, 2013
TCL Archive ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval By Cancer History Project September 13, 2013
TCL Archive ODAC Unanimously Rejects Melblez, Citing Lower Survival By Cancer History Project May 17, 2013
TCL Archive Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC By Cancer History Project August 10, 2012
TCL Archive Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin By Cancer History Project July 27, 2012
ArticleSpotlight Article A Vote for Cancer: Tobacco Advertising and Presidential Elections By The Center for the Study of Tobacco and Society